Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain — Stella

Home/Neuropathic Pain/Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain

View on ClinicalTrials.gov

Recruiting

Back to Neuropathic Pain trials

Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Brazil

Allegisa, Campinas, São Paulo

Key details

Phase

Large-scale testing

Sponsor

EMS

Enrollment target

~136 participants

Started

May 2023

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.